Answers are grounded in this paper and cite their sources.
Objective: The urinary albumin-to-creatinine ratio (uACR) has limited sensitivity for early structural changes in diabetic kidney disease (DKD), prompting interest in novel circulating biomarkers. This cross-sectional study evaluated the combined diagnostic association of serum Netrin-1 and Growth Differentiation Factor-15 (GDF-15) across albuminuria stages in type 2 diabetes mellitus (T2DM). Methods: Sixty T2DM patients (stratified by albuminuria: normo-, micro-, and macroalbuminuria, n=20 each) and 60 age- and BMI-matched healthy controls were enrolled. Serum Netrin-1 and GDF-15 were quantified by sandwich ELISA. Estimated glomerular filtration rate (eGFR) was calculated using the race-free CKD-EPI 2021 equation. ROC analysis and multivariable logistic regression were performed. Results: Netrin-1 and GDF-15 were significantly elevated in T2DM versus controls (p=0.004 and p=0.001, respectively). Netrin-1 peaked in microalbuminuria (495.2±102.7 pg/mL) while GDF-15 was highest in macroalbuminuria (406.6±106.8 ng/L; ANOVA p=0.020 and p=0.041). Single-marker AUCs: Netrin-1 0.725 (95%CI:0.635-0.816), GDF-15 0.708 (95%CI:0.615-0.800); combined model AUC 0.743 (95%CI:0.655-0.831; p=0.032 vs GDF-15 alone). In adjusted analysis, only eGFR (aOR=0.945 per mL/min/1.73m², p<0.001) and BMI (aOR=1.195 per kg/m², p=0.023) independently predicted T2DM status; biomarker associations attenuated to non-significance. Conclusion: Serum Netrin-1 and GDF-15 show stage-specific patterns across albuminuria in T2DM but provide only modest incremental diagnostic value over conventional renal indices. These findings are hypothesis-generating; longitudinal studies with hard renal endpoints are required to establish clinical utility.
No takes yet. Share an insight, caveat, or question.
Tami et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: